Admetsys has developed the first fully-automated glucose control system (artificial pancreas) specifically for the needs of hospital & surgical care. 〽️
Join Admetsys at 14:30pm GMT on 2nd December 2020 online at GIANT 2020 @gianthealthevnt to learn more about Admetsys' PrecisionOne™ Automated Glycemic Control and Continuous Diagnostics System for Hospital and Surgical Care. https://t.co/95jgv0dSml
#TechTop50Honoree Congrats to .@admetsys for their PrecisionOne system that functions as a metabolic autopilot, providing automated gluclose regulation and real-time blood chemistry analysis for diabetes patients👏 #Innovation
Admetsys is honored to be nominated to the @MassTLC Tech Top 50 program for the recent CE Mark approval of the novel PrecisionOne™ Automated Glycemic Control and Continuous Diagnostics System. #ThankYou https://t.co/Fa7gQlKC47
Poorly-controlled glucoses in hospitalized #COVID19 patients increases death rates significantly. "These findings provide clinical evidence correlating improved glycemic control with better outcomes in patients with COVID-19 and pre-existing T2D." https://t.co/ARCA66hw6O
Admetsys is proud to announce that we have received a CE mark in Europe. Thank you to all of our advocates, advisors and investors for helping us change the landscape of hospital care. @T1DExchange@dreamit@BaptistHealthAR@ArkBlueCross@ZellLurie
All the companies did amazing last night. Thank you to everyone who help made this possible.
The Finale Results on the war on COVID Competition
1 st place Lincoln advantage technologies
2nd place @admetsys
And a tie for crowd favorite
@PhenoMxInc
and
@elemenohealth
Watch @Admetsys present on creating value for patients and healthcare at #efpPhilly @eyeforpharma Philadelphia Virtual, the largest commercial pharma conference, on April 14th at 5 PM ET. Register at https://t.co/JckSwmFIGX #ArtificialPancreas#T1D
Thank you to @MedStartr@Health2eu#Health20NYC for allowing us to join the #WarOnCOVID Challenge during these unique times. We look forward to working with you and other innovators as we jointly work towards mitigating #COVID19 and supporting medical staff and patients.
See @Admetsys and other great innovators present online tomorrow as part of the @MedStartr@Health2eu#Health20NYC#WarOnCOVID Challenge as we work towards mitigating #COVID19 through information-driven scalable diagnostics and automated care. Join via https://t.co/YQAJTKBZk8
The MBRIF has two distinct offerings for startups: 1. Accelerator 2. Government backed guarantees. Admetsys, a Boston based medical startup, was a member of our accelerator’s first cohort. This facilitated their growth in the UAE & other countries outside of their home turf.
👇
Their accelerator journey enabled them to kick-off qualification discussions for the Guarantee Scheme, which provides financial solutions for innovative companies. Get in touch and learn more here: https://t.co/97EjBQVVdd
#MBRIF